Barclays Maintains Equal-Weight on Johnson & Johnson, Lowers Price Target to $158
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Matt Miksic has maintained an Equal-Weight rating on Johnson & Johnson (NYSE:JNJ) but lowered the price target from $175 to $158.
September 08, 2023 | 7:02 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Barclays has maintained an Equal-Weight rating on Johnson & Johnson but lowered the price target from $175 to $158.
The lowering of the price target by Barclays indicates a potential decrease in the stock price of Johnson & Johnson in the short term. This is likely to have a negative impact on the stock's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100